The possible role of glutathione-S-transferase activity in diabetic nephropathy

International Journal of Immunopathology and Pharmacology

Volumn 28, Issue 1, 2015, Pages 129-133

  Tesauro, M ^a   Nistico S ^b   Noce, A ^a   Tarantino, A ^a   Marrone, G ^a   Costa, A ^c   Rovella, V ^a   Di Cola, G ^a   Campia, U ^d   Lauro, D ^a   Cardillo, C ^e   Di Daniele, N ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d MedStar Cardiovascular Research Network   (United States)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

Biomarkers; Diabetic nephropathy; Glutathione S transferase; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; ERYTHROCYTE ENZYME; ERYTHROCYTE GLUTATHIONE S TRANSFERASE\; GLUTATHIONE TRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; MICROALBUMINURIA; PRIORITY JOURNAL; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; METABOLISM;

BIOMARKERS; DIABETES COMPLICATIONS; DIABETIC NEPHROPATHIES; GLUTATHIONE TRANSFERASE; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL INSUFFICIENCY, CHRONIC;

EID: 84959302197     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/0394632015572564     Document Type: Article

References (29)

1. Choudhary N and Ahlawat RS (2008) Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: New evidence linking inflammation, glycemic control, and microalbuminuria. Iranian Journal of Kidney Diseases 2: 72-79.
2. Tesauro M, Mascali A, Franzese O et al. (2012) Chronic kidney disease, obesity, and hypertension: The role of leptin and adiponectin. International Journal of Hypertension 2012: 943605.
3. Rosolowsky ET, Skupien J, Smiles AM, et al. (2011) Risk for ESRD in type 1 diabetes remains high despite renoprotection. Journal of the American Society of Nephrology 22: 545-553.
4. Viberti GC, Hill RD, Jarrett RJ et al. (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 26: 1430-1432.
5. Williams ME (2005) Diabetic nephropathy: The proteinuria hypothesis. American Journal of Nephrology 5: 77-94.
6. Tesauro M, Canale MP, Rodia G et al. (2011) Metabolic syndrome, chronic kidney, and cardiovascular diseases: Role of adipokines. Cardiology Research and Practice 7: 2011.
7. Perkins BA, Ficociello LH, Silva KH et al. (2003) Regression of microalbuminuria in type 1 diabetes. New England Journal of Medicine 348: 2285-2293.
8. De Boer IH, Rue TC, Cleary PA, et al. (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Archives of Internal Medicine 14: 412-420.
9. Perkins BA, Ficociello LH, Roshan B et al. (2010) In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney International 77: 57-64.
10. Sailaja YR, Baskar R and Saralakumari D (2003) The antioxidant status during maturation of reticulocytes to erythrocytes in type 2 diabetics. Free Radical Biology & Medicine 35: 133-139.
11. Annadurai T, Vasanthakumar A, Geraldine P et al. (2014) Variations in erythrocyte antioxidant levels and lipid peroxidation status and in serum lipid profile parameters in relation to blood haemoglobin A1c values in individuals with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 105: 58-69.
12. Giebułtowicz J, Sołobodowska S, Bobilewicz D et al. (2014) Blood ALDH1 and GST activity in diabetes type 2 and its correlation with glycated hemoglobin. Experimental and Clinical Endocrinology & Diabetes 122: 55-59.
13. Datta SK, Kumar V, Ahmed RS et al. (2010) Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients. Indian Journal of Biochemistry & Biophysics 47: 100-103.
14. Ceriello A, Morocutti A, Mercuri F et al. (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49: 2170-2177.
15. Bid HK, Konwar R, Saxena M et al. (2010) Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. Journal of Postgraduate Medicine 56: 176-181.
16. Bekris LM, Shephard C, Peterson M, et al. (2005) Glutathione-s-transferase M1 and T1 polymorphisms and associations with type 1 diabetes age-at-onset. Autoimmunity 38: 567-575.
17. Jiang B, Guo L, Li BY, et al. (2013) Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione S-transferase Mu in diabetic rats. Journal of Medicinal Food 16: 481-486.
18. Holmquist P and Liuba P (2012) Urine α-Glutathione S-transferase, systemic inflammation and arterial function in juvenile type 1 diabetes. Journal of Diabetes and its Complications 26: 199-204.
19. Sheehan D, Meade G, Foley VM et al. (2001) Structure, function and evolution of glutathione transferases: Implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochemical Journal 360: 1-16.
20. Armstrong RN (1997) Structure, catalytic mechanism, and evolution of the glutathione transferases. Chemical Research in Toxicology 10: 2-18.
21. Singhal SS, Gupta S, Ahmad H et al. (1990) Characterization of a novel alpha-class anionic glutathione S-transferase isozyme from human liver. Archives of Biochemistry and Biophysics 15: 45-53.
22. Galli F, Rovidati S, Benedetti S et al. (1999) Over-expression of erythrocyte glutathione-S-transferase in uremia and dialysis. Clinical Chemistry 45: 1781-1788.
23. Noce A, Ferrannini M, Fabrini R, et al. (2012) Erythrocyte glutathione transferase: A new biomarker for hemodialysis adequacy, overcoming the Kt/V(urea) dogma? Cell Death & Disease 23: e377.
24. Carmagnol F, Sinet PM, Rapin J et al. (1981) Glutathione-S-transferase of human red blood cells; assay, values in normal subjects and in two pathological circumstances: Hyperbilirubinemia and impaired renal function. Clinica Chimica Acta 117: 209-217.
25. Dessì M, Noce A, Dawood KF, et al. (2012) Erythrocyte glutathione transferase: A potential new biomarker in chronic kidney diseases which correlates with plasma homocysteine. Amino Acids 43: 347-354.
26. Noce A, Fabrini R, Dessì M, et al. (2014) Erythrocyte glutathione transferase activity: A possible early biomarker for blood toxicity in uremic diabetic patients. Acta Diabetologica 51: 219-224.
27. Li Vecchi M, Fuiano G, Francesco M, et al. (2007) Prevalence and severity of anaemia in patients with type II diabetic nephropathy and different degrees of chronic renal insufficiency. Nephron Clinical Practice 105: c62-67.
28. Specchio F, Saraceno R, Chimenti S et al. (2014) Cutaneous manifestations. International Journal of Immunopathology and Pharmacology 27: 1-4
29. Chiricozzi A, Pitocco R, Saraceno R et al. (2014) New topical treatments for psoriasis. Expert Opinion on Pharmacotherapy 15: 461-470.